Elizabeth Moberg Wolff, MD
Pediatric Rehabilitation Medicine · Wauwatosa, WINPI 1184677825
Payments from drug & device makers
Across 130 payments — averaging $296.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Piramal Critical Care$18K
- MDD US Operations, LLC$10K
- Merz North America, Inc.$5K
- Merz Pharmaceuticals, LLC$5K
- AbbVie$352
- Amneal Pharmaceuticals LLC$38
- plus $64 from 3 others
Across 1 payment — averaging $9000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merz Pharmaceuticals, LLC$9K
What the payments were for
- Consulting fees$9,11624%
- Speaking & faculty fees$22,80059%
- Travel & lodging$3,95710%
- Food & beverage$2,6707%
- Education$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Piramal Critical Care | 38 | $18,089 |
| MDD US Operations, LLC | 33 | $9,789 |
| Merz North America, Inc. | 21 | $5,189 |
| Merz Pharmaceuticals, LLC | 18 | $5,043 |
| AbbVie(2 entities) | 15 | $352 |
| Amneal Pharmaceuticals LLC | 2 | $38 |
| AstraZeneca | 1 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GABLOFEN$69,097
- XEOMIN$9,482
- MYOBLOC$7,615
- MITIGO$4,036
- GABLOFEN 1 mL in 1 SYRINGE, GLASS$300
How this compares
Too few pediatric rehabilitation medicine providers in Wisconsinto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dantrolene Sodium | 55 | $4,961 |
| Baclofen | 160 | $4,520 |
| Glycopyrrolate | 47 | $1,453 |
| Paroxetine Hcl | 14 | $992 |
| Clonidine | 11 | $791 |
| Buspirone Hcl | 34 | $600 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 11 | $487 |
| Gabapentin | 24 | $375 |
| Diclofenac Sodium ErDiclofenac Sodium | 12 | $352 |
| Trihexyphenidyl Hcl | 21 | $291 |
| Pregabalin | 11 | $171 |
| Sertraline Hcl | 15 | $168 |
Paid to pharmacies, not to this prescriber.
Other pediatric rehabilitation medicine in Wauwatosa
- Britney PappMarshfield$383
- Lauren FetskoMadison$227
- Amanda LindenbergMiddleton$53
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.